E-LIB Suche - Ergebnisse für: Latif, Anne Louise

1

Implications of CAR‐T cell therapy on apheresis services: a..:

Horne, Gillian A. ; Laird, Jennifer ; Latif, Anne Louise...
Journal of Clinical Apheresis. 36 (2020) 3 - p. 513-515 , 2020

Link: https://doi.org/10.1002/..

2

Real-world outcomes of newly diagnosed AML treated with ven..:

Othman, Jad ; Lam, Ho Pui Jeff ; Leong, Sarah...
Blood Neoplasia. 1 (2024) 3 - p. 100017 , 2024

Link: https://doi.org/10.1016/..

3

Molecular MRD is strongly prognostic in patients with NPM1-..:

Othman, Jad ; Tiong, Ing S. ; O'Nions, Jenny...
Blood. 143 (2024) 4 - p. 336-341 , 2024

Link: https://doi.org/10.1182/..

4

Critical care utilisation for patients receiving chimeric a..:

Pirani, Tasneem ; Wilson, Anthony ; Brealey, David...
British Journal of Anaesthesia. 132 (2024) 5 - p. 1004-1006 , 2024

Link: https://doi.org/10.1016/..

5

FLT3 inhibitors as MRD-guided salvage treatment for molecul..:

Othman, Jad ; Potter, Nicola ; Mokretar, Katya...
Leukemia. 37 (2023) 10 - p. 2066-2072 , 2023

Link: https://doi.org/10.1038/..

6

BRD4-mediated repression of p53 is a target for combination..:

Latif, Anne-Louise ; Newcombe, Ashley ; Li, Sha...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

7

3102 – A SYNTHETIC LETHALITY APPROACH TO ERADICATE AML VIA ..:

Li, Sha ; Latif, Anne-Louise ; Newcombe, Ashley...
Experimental Hematology. 88 (2020) - p. S70 , 2020

Link: https://doi.org/10.1016/..

8

Lifting the Differentiation Embargo:

Latif, Anne-Louise ; Holyoake, Tessa L.
Cell. 167 (2016) 1 - p. 45-46 , 2016

Link: https://doi.org/10.1016/..

9

Allogeneic stem cell transplantation for chronic myeloid le..:

Latif, Anne-Louise ; McQuaker, Grant ; Parker, Anne..
Leukemia Research Reports. 2 (2013) 2 - p. 47-50 , 2013

Link: https://doi.org/10.1016/..

10

Splenectomy as an effective debulking therapy for dissemina..:

Latif, Anne-Louise ; Harper, Chrsitina ; Macdonald, Ian.
Medical Mycology Case Reports. 1 (2012) 1 - p. 82-84 , 2012

Link: https://doi.org/10.1016/..

11

FLT3 inhibitors as MRD-guided salvage treatment for molecul..:

Othman, Jad ; Potter, Nicola ; Mokretar, Katya...
Othman , J , Potter , N , Mokretar , K , Taussig , D , Khan , A , Krishnamurthy , P , Latif , A L , Cahalin , P , Aries , J , Amer , M , Belsham , E , Conneally , E , Craddock , C , Culligan , D , Dennis , M , Duncan , C , Freeman , S D , Furness , C , Gilkes , A , Gkreka , P , Hodgson , K , Ingram , W , Jain , M , King , A , Knapper , S , Kottaridis , P , McMullin , M F , Mohite , U , Ngu , L , O'Nions , J , Patrick , K , Rider , T , Roberts , W , Severinsen , M T , Storrar , N , Taylor , T , Russell , N H & Dillon , R 2023 , ' FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML ' , Leukemia , vol. 37 , no. 10 , pp. 2066-2072 . https://doi.org/10.1038/s41375-023-01994-x. , 2023

Link: https://vbn.aau.dk/da/pu..

12

FLT3 inhibitors as MRD-guided salvage treatment for molecul..:

Othman, Jad ; Potter, Nicola ; Mokretar, Katya...
Othman , J , Potter , N , Mokretar , K , Taussig , D , Khan , A , Krishnamurthy , P , Latif , A-L , Cahalin , P , Aries , J , Amer , M , Belsham , E , Conneally , E , Craddock , C , Culligan , D , Dennis , M , Duncan , C , Freeman , S D , Furness , C , Gilkes , A , Gkreka , P , Hodgson , K , Ingram , W , Jain , M , King , A , Knapper , S , Kottaridis , P , McMullin , M F , Mohite , U , Ngu , L , O'Nions , J , Patrick , K , Rider , T , Roberts , W , Severinsen , M T , Storrar , N , Taylor , T & Russell , N H 2023 , ' FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML ' , Leukemia . https://doi.org/10.1038/s41375-023-01994-x. , 2023

Link: https://pure.qub.ac.uk/e..

13

FLT3 inhibitors as MRD-guided salvage treatment for molecul..:

Othman, Jad ; Potter, Nicola ; Mokretar, Katya...
Othman , J , Potter , N , Mokretar , K , Taussig , D , Khan , A , Krishnamurthy , P , Latif , A-L , Cahalin , P , Aries , J , Amer , M , Belsham , E , Conneally , E , Craddock , C , Culligan , D , Dennis , M , Duncan , C , Freeman , S D , Furness , C , Gilkes , A , Gkreka , P , Hodgson , K , Ingram , W , Jain , M , King , A , Knapper , S , Kottaridis , P , McMullin , M F , Mohite , U , Ngu , L , O'Nions , J , Patrick , K , Rider , T , Roberts , W , Severinsen , M T , Storrar , N , Taylor , T & Russell , N H 2023 , ' FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML ' , Leukemia . https://doi.org/10.1038/s41375-023-01994-x. , 2023

Link: https://pure.qub.ac.uk/e..

14

BRD4-mediated repression of p53 is a target for combination..:

Latif, Anne-Louise ; Newcombe, Ashley ; Li, Sha...
https://eprints.gla.ac.uk/228000/1/228000.pdf. , 2021

Link: https://eprints.gla.ac.u..

15

BRD4-mediated repression of p53 is a target for combination..:

Latif, Anne-Louise ; Newcombe, Ashley ; Li, Sha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801601/. , 2021

Link: http://www.ncbi.nlm.nih...